Overview
DBCO-functionalized polysaccharides are advanced biomaterials created by conjugating dibenzocyclooctyne (DBCO) groups onto natural polysaccharide backbones like dextran, hyaluronic acid, or chitosan. This modification enables strain-promoted azide-alkyne cycloaddition (SPAAC), a copper-free click chemistry reaction prized for its bioorthogonality. The technology emerged in the early 2010s as a solution for biomolecule labeling in live systems where traditional copper-catalyzed click reactions prove cytotoxic. These engineered polymers combine the biocompatibility of natural polysaccharides with the precise conjugation capabilities of DBCO. They serve as versatile platforms in pharmaceutical development, particularly for creating targeted drug delivery systems. The degree of DBCO substitution (typically 5–20%) can be tailored to balance reactivity with the polysaccharide's native properties.
Physical and Chemical Properties
The physical properties of DBCO-polysaccharides primarily reflect their base polysaccharide, with DBCO groups (typically <2 mmol/g) introducing hydrophobic character. Fourier-transform infrared spectroscopy (FTIR) confirms modification via characteristic DBCO peaks at 2120 cm⁻¹ (C≡C stretch) and 1590 cm⁻¹ (aromatic C=C). Unlike small-molecule DBCO reagents, these conjugates maintain water solubility through the polysaccharide's hydrophilic groups. Dynamic light scattering shows particle sizes ranging from 10–200 nm in solution, depending on the polymer's molecular weight. The DBCO groups exhibit stability in physiological conditions (pH 5–8, 37°C) for days, though prolonged storage requires protection from moisture and oxygen to prevent slow hydrolysis.
Main Applications
In drug delivery, DBCO-polysaccharides enable modular assembly of antibody-drug conjugates (ADCs) by reacting with azide-modified targeting moieties. For example, DBCO-hyaluronan forms tumor-targeting hydrogels when crosslinked with azide-bearing peptides. The pharmaceutical industry values these materials for creating uniform conjugates without metal catalysts. Diagnostic applications include flow cytometry reagents where DBCO-dextran rapidly labels azide-tagged cell surface markers. Tissue engineers utilize DBCO-chitosan scaffolds for spatially controlled growth factor immobilization. Emerging uses span DNA nanotechnology (assembling polysaccharide-coated nanoparticles) and biosensor development (creating carbohydrate-based detection interfaces).
Safety and Storage
While DBCO-polysaccharides are generally biocompatible (ISO 10993-5 tested), workplace handling requires nitrile gloves and particulate masks due to potential respiratory irritation from fine powders. The DBCO moiety may cause mild skin sensitization in susceptible individuals. Optimal storage involves argon-purged vials at -20°C, with desiccant to prevent moisture absorption. Lyophilized products typically maintain reactivity for 2+ years when properly stored, while solutions in PBS (pH 7.4) remain stable for ~1 week at 4°C. Endotoxin levels should be <0.1 EU/mg for in vivo applications, requiring aseptic processing during manufacturing.
B2B Procurement Guide
Industrial buyers should specify: 1) Polysaccharide type and molecular weight (e.g., 40 kDa dextran), 2) DBCO substitution rate (mmol/g), 3) Residual solvent levels (<500 ppm DMSO), and 4) Sterility requirements. Bulk orders (100g+) often qualify for 15–30% discounts but require lead times of 8–12 weeks for custom syntheses. Quality verification should include NMR confirmation of DBCO attachment (δ 7.2–7.8 ppm aromatic protons) and HPLC purity analysis (>95%). For GMP-grade materials, request certificates of analysis covering heavy metals (<10 ppm), bioburden, and endotoxin testing. Reliable suppliers provide batch-specific reactivity data using standard azide titration methods.
Related Manufacturers
- 主营：嵌段共聚物、合成磷脂、荧光染料、点击化学、PEG、量子点
- 主营：甲氧基聚乙二醇、氨基聚乙二醇、羧基聚乙二醇、巯基聚乙二醇、羟基聚乙二醇、马来酰亚胺聚乙二醇、四臂聚乙二醇、荧光素聚乙二醇、叠氮聚乙二醇、硅烷聚乙二醇、炔基聚乙二醇、生物素聚乙二醇、丙烯酸酯聚乙二醇、活性脂聚乙二醇、Boc保护基团聚乙二醇、Fmoc保护基团聚乙二醇、生物素小分子PEG衍生物、甲氧基小分子PEG衍生物